For the last several quarters, Gilead Sciences’ earnings calls have been colored by anticipation for the launch of the California drugmaker's long-acting HIV pre-exposure prophylaxis (PrEP) option. | ...

Gilead Sciences, Inc.’s GILD posted 3% year-over-year growth in total revenues for the third quarter of 2025. Total revenues comprise product sales and royalty, contract and other revenues. While ...

Oral HIV pre-exposure prophylaxis (PrEP) adoption varies across the US, with posters presented at the Academy of Managed Care Pharmacy Nexus 2025 meeting in National Harbor, Maryland, highlighting ...

A brand new drug might be more effective at preventing HIV than current methods. Many people take daily oral antiretroviral medication—known as PrEP (pre-exposure prophylaxis)—to protect themselves ...

The city's axess sexual health service is piloting a new online platform that will deliver preventative HIV medication PrEP ...

Increased PrEP usage is linked to decreased HIV diagnosis rates, with a notable decline from 13.0 to 10.6 per 100,000 over a decade. State-level PrEP coverage significantly impacts HIV diagnosis rates ...

Cabotegravir was already approved for use in England and Wales as part of a combination treatment for people living with HIV.

Sara Moniuszko is a health and lifestyle reporter at CBSNews.com. Previously, she wrote for USA Today, where she was selected to help launch the newspaper's wellness vertical. She now covers breaking ...

Please provide your email address to receive an email when new articles are posted on . The recommendation is consistent with the task force’s 2022 draft and 2019 final recommendations. Risk factors ...

Robin O’Donoghue grew up in Fairbanks and first heard about pre-exposure prophylaxis, or PrEP, for preventing HIV transmission when he was in college. PrEP is a daily pill or injection that ...

A new pre-exposure prophylaxis (PrEP) drug has shown promise as a once-monthly oral pill to help prevent HIV. PrEP plays a key part in reducing the number of new HIV infections by stopping the virus ...

Some lawmakers and advocates are increasingly uncertain whether critical HIV and AIDS services will survive the federal government’s funding fight. The GOP’s House-passed budget bill seeks to cut ...